Physician profile
Nicole Quick
NPI 1093291916
$209.93
in general payments reported to CMS, 2019-2025
9 companies · $37.59 in 2025
The $37.59 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2.91 · 2022: $17.26 · 2023: $112 · 2024: $40.01 · 2025: $37.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $43.37 | 2023 | |
| Cranial Technologies, INC | $39.78 | 2024-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $25.39 | 2023 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $22.13 | 2023 | Elaprase |
| Galderma Laboratories, L.P. | $21.27 | 2023 | |
| Glaxosmithkline, LLC. | $20.77 | 2024 | Bexsero |
| Seqirus USA INC | $17.26 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.05 | 2025 | Zoryve |
| Genentech USA, INC. | $2.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Quick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.